iPLATO Hub to Help Government Boost Uptake of NHS Health Checks

iPLATO HealthcareiPLATO Healthcare, a UK leader in cloud based mHealth and Analytics, welcomes the new government mandate to re-launch NHS Health Checks to reach 15 million patients over the next 5 years. In a number of trials in recent years the iPLATO service has proven to help engage target patients around NHS Health Checks and cost effectively reach screening targets. iPLATO states its commitment to help Public Health England reach its ambitious target through further development to its iPLATO Hub product to include letter and phone calls in addition to its existing mix of digital engagement - SMS, Apps and Video.

"NHS Health Checks has been a popular campaign for our Public Health and GP Practice partners for some time," says Tobias Alpsten, CEO of iPLATO. "Practices use iPLATO to engage patients and invite for NHS Health Checks every year. Using iPLATO Hub, local and regional Public Health teams can tap into this existing communication capability and transform overall performance through very sophisticated multi-channel campaigns. This is a huge step up from traditionally laborious processes for informing patients about NHS Health Checks and inviting them to book an appointment."

Kim, IT Manager at Brondesbury Medical Centre, an iPLATO user says, "Mobile phones are used by most of our patients and so text messaging is an effective way to communicate with them especially around NHS Health Checks. This service has the potential to significantly increase the number of patients attending clinics as well as saving on surgery administration costs."

In a document laying out its priorities for 2013-16 Public Health England said all 40 to 74 year olds will be offered health checks, which were introduced in 2009 with the aim of preventing heart disease, stroke, diabetes, kidney disease and certain types of dementia. Public Health England said one of its priorities was to reduce preventable deaths and to do this it would 'support people to live healthier lives by implementing NHS Health Checks to 15 million eligible people.'

Related news articles:

About iPLATO
iPLATO Healthcare is British innovation company. iPLATO’s evidence based mobile health solutions have proven to improve patient access to healthcare, to enable powerful health promotion targeted at people at risk and to support people with long term conditions.

Serving millions of patients and thousands of healthcare professionals every day iPLATO has emerged as the leader in mobile health. Across this network the company is running campaigns to promote smoking cessation, weight loss, childhood immunisation and pandemic awareness as well as mobile disease management services for people with diabetes, hypertension, epilepsy and HIV.

iPLATO Healthcare's mission is to, in partnership with clinicians, help healthcare commissioners transform patient care through cloud based mHealth and Analytics.

Most Popular Now

MEDICA 2024 + COMPAMED 2024: Adapted Hal…

11 - 14 November 2024, Düsseldorf, Germany. The final preparations for MEDICA 2024 and COMPAMED 2024 in Düsseldorf have begun. A total of more than 5,500 exhibitors from approximately 70 countries...

AI does Not Necessarily Lead to more Eff…

The use of artificial intelligence (AI) in hospitals and patient care is steadily increasing. Especially in specialist areas with a high proportion of imaging, such as radiology, AI has long...

Commission Joins Forces with Venture Cap…

The Commission has launched a Trusted Investors Network bringing together a group of investors ready to co-invest in innovative deep-tech companies in Europe together with the EU. The Union's investment...

Why the NHS is Seeking to Make Media Ser…

Opinion Article by Dean Moody, Healthcare Services Director, Airwave Healthcare. Tim Kelsey and Martha Lane Fox called for WiFi to be made available free of charge throughout the NHS back in...

An AI-Powered Pipeline for Personalized …

Ludwig Cancer Research scientists have developed a full, start-to-finish computational pipeline that integrates multiple molecular and genetic analyses of tumors and the specific molecular targets of T cells and harnesses...

Philips and Medtronic Advocacy Partnersh…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Medtronic Neurovascular, a leading innovator in neurovascular therapies, today announced a strategic advocacy partnership. Delivering timely stroke...

Wearable Cameras Allow AI to Detect Medi…

A team of researchers says it has developed the first wearable camera system that, with the help of artificial intelligence (AI), detects potential errors in medication delivery. In a test whose...

AI could Transform How Hospitals Produce…

A pilot study led by researchers at University of California San Diego School of Medicine found that advanced artificial intelligence (AI) could potentially lead to easier, faster and more efficient...

New AI Tool Predicts Protein-Protein Int…

Scientists from Cleveland Clinic and Cornell University have designed a publicly-available software and web database to break down barriers to identifying key protein-protein interactions to treat with medication. The computational tool...

AI for Real-Rime, Patient-Focused Insigh…

A picture may be worth a thousand words, but still... they both have a lot of work to do to catch up to BiomedGPT. Covered recently in the prestigious journal Nature...

Start-Ups will Once Again Have a Starrin…

11 - 14 November 2024, Düsseldorf, Germany. The finalists in the 16th Healthcare Innovation World Cup and the 13th MEDICA START-UP COMPETITION have advanced from around 550 candidates based in 62...

G-Cloud 14 Makes it Easier for NHS to Bu…

NHS organisations will be able to save valuable time and resource in the procurement of technologies that can make a significant difference to patient experience, in the latest iteration of...